 Solution

In this trial, MAR means that among patients assigned the same treatment who have the same recorded QoL trajectory up to a visit, the probability of dropping out next is unrelated to what their later QoL values would have been. Dropout may depend strongly on previous poor QoL, treatment assignment, and other observed history; MAR only rules out residual dependence on the unobserved outcomes.